These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9500883)

  • 1. Neurological motor disorders experienced as religious phenomena: role of abnormal movement monitoring.
    Lauerma H; Tuliharju M
    Brain Cogn; 1998 Feb; 36(1):52-6. PubMed ID: 9500883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-effects of language on risk perception in drug prescribing behavior.
    Bursztajn HJ; Chanowitz B; Gutheil TG; Hamm RM
    Bull Am Acad Psychiatry Law; 1992; 20(1):59-66. PubMed ID: 1349499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
    Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of psychosis and movement disorders in the elderly.
    Lohr JB; Bracha HS
    Psychiatr Clin North Am; 1988 Mar; 11(1):61-81. PubMed ID: 2898137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling effective treatment of psychoses in the elderly: a focus on avoiding movement disorders.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S247-8. PubMed ID: 15541164
    [No Abstract]   [Full Text] [Related]  

  • 7. [Motor disturbances in psychosis].
    Putzhammer A; Hajak G
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S1-2. PubMed ID: 15818514
    [No Abstract]   [Full Text] [Related]  

  • 8. Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology.
    Caligiuri MP; Lohr JB; Ruck RK
    Psychophysiology; 1998 Jul; 35(4):431-7. PubMed ID: 9643057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam in tardive dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
    Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J; Targum SD
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal neurological signs at the onset of psychosis.
    Scheffer RE
    Schizophr Res; 2004 Sep; 70(1):19-26. PubMed ID: 15246459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interface between religion and psychosis.
    Ng F
    Australas Psychiatry; 2007 Feb; 15(1):62-6. PubMed ID: 17464638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on legal issues associated with tardive dyskinesia.
    Slovenko R
    J Clin Psychiatry; 2000; 61 Suppl 4():45-57. PubMed ID: 10739331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculogyric crisis with exacerbation of psychosis: Possible mechanism and clinical implications.
    Thomas N; Sankar SS; Braganza D; Jayakrishnan S
    Neurosci Lett; 2009 Feb; 451(1):50-1. PubMed ID: 19121367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
    Fernandez HH; Trieschmann ME; Burke MA; Jacques C; Friedman JH
    Mov Disord; 2003 May; 18(5):510-4. PubMed ID: 12722164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical antipsychotics in the elderly].
    van Melick EJ;
    Tijdschr Gerontol Geriatr; 2004 Dec; 35(6):240-5. PubMed ID: 15704604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J; Walsh E; van Horn E; Tattan T; Bale R; Thompson SG
    Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.